909135-34-8

Basic information

• Product Name: tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azabicyclo[3.3.1]non-7-ene-3-carboxylate
• Synonyms: tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azabicyclo[3.3.1]non-7-ene-3-carboxylate
• CAS NO: 909135-34-8
• Molecular Weight: 349.278
• Mol File: 909135-34-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azabicyclo[3.3.1]non-7-ene-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azabicyclo[3.3.1]non-7-ene-3-carboxylate(909135-34-8)
• EPA Substance Registry System: tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azabicyclo[3.3.1]non-7-ene-3-carboxylate(909135-34-8)

Safety Data

• Hazardous Substances Data: 909135-34-8(Hazardous Substances Data)

Upstream product

• 909135-33-7 tert-butyl 7-(trifluoromethylsulfonyloxy)-3-azabicyclo[3.3.1]non-7-ene-3-carboxylate 
• 73183-34-3 bis(pinacol)diborane 
• 909135-31-5 tert-butyl 7-oxo-3-azabicyclo[3.3.1]nonane-3-carboxylate 
• 909135-27-9 3-benzyl-3-azaspirobicyclo[3.3.1]nonane-7,2′-[1,3]dioxolane 
• 1403377-50-3 1,4-dioxaspiro[4,5]decane-7,9-dicarbaldehyde 
• 87122-06-3 dimethyl 5-oxocyclohexane-1,3-dicarboxylate 
• 909135-32-6 tert-butyl-7H-spiro[7-azabicyclo[3.3.1]nonane-3.2'-[1,3]dioxolane]-7-carboxylate 
• 199874-18-5 spiro[7-azabicyclo[3.3.1]nonane-3.2'-[1,3]dioxolane] 
• 64860-12-4 1,4-dioxa-spiro[4.5]decane-7,9-dicarboxylic acid dimethyl ester 
• 113474-25-2 5-hydroxy-cyclohexane-1,3-dicarboxylic acid dimethyl ester 
• 13036-02-7 Dimethyl 5-hydroxyisophthalate 

Downstream Products

• 909135-37-1 tert-butyl-7-(3,4-difluorophenyl)-3-azabicyclo[3.3.1]non-6-ene-3-carboxylate 
• 1403376-90-8 C₁₉H₂₀N₂ 

Relevant articles and documents

Structure-activity studies of 7-heteroaryl-3-azabicyclo[3.3.1]non-6-enes: A novel class of highly potent nicotinic receptor ligands

The potential for nicotinic ligands with affinity for the α4β2 or α7 subtypes to treat such diverse diseases as nicotine addiction, neuropathic pain, and neurodegenerative and cognitive disorders has been exhibited clinically for several compounds while p